MedDRA stands for Medical Dictionary for Regulatory Activities. It is a standardized medical terminology developed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).
MedDRA is used internationally to classify adverse event information associated with the use of biopharmaceuticals and other medical products. It provides a consistent way to encode and analyze medical data throughout the regulatory process, from pre-marketing to post-marketing activities.
MedDRA is crucial in clinical research for ensuring consistency and accuracy in reporting adverse events and medical conditions. Its standardized terminology allows researchers and regulatory authorities to efficiently analyze safety data across different studies, pharmaceutical companies, and geographic regions.
The use of MedDRA facilitates clear communication between stakeholders in the drug development process, including sponsors, investigators, and regulatory agencies. It enhances the quality of safety signal detection and evaluation, ultimately contributing to better patient safety and more effective pharmacovigilance practices.
How Axcellant stabilized isotope supply, synchronized global imaging operations, and prevented a multi-month program delay. At a Glance Study type:…
At Axcellant, we work where medtech becomes real, not in headlines but in clinics, documentation, and decisions that must stand…
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
Copyright @ 2026 Axcellant